Philip R. Selby

Port Road
Adelaide, SA, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Infection risk in myelodysplastic syndromes is dynamic and immune driven.

Infection risk in myelodysplastic syndromes is dynamic and immune driven.

Journal: Blood advances

Published: January 27, 2026

Understanding antiviral intolerance in the management of cytomegalovirus; a scoping review.

Understanding antiviral intolerance in the management of cytomegalovirus; a scoping review.

Journal: Current opinion in infectious diseases

Published: October 28, 2025

Exploring Health Care Professionals' Engagement With a Precision Dosing Calculator and Supporting Clinical Information: Insights From an Eye-Tracking and Usability Study.

Exploring Health Care Professionals' Engagement With a Precision Dosing Calculator and Supporting Clinical Information: Insights From an Eye-Tracking and Usability Study.

Journal: Therapeutic drug monitoring

Published: November 26, 2024

Determination of a vancomycin nephrotoxicity threshold and assessment of target attainment in hematology patients.

Determination of a vancomycin nephrotoxicity threshold and assessment of target attainment in hematology patients.

Journal: Pharmacology research & perspectives

Published: February 13, 2024

Population pharmacokinetics of posaconazole in allogeneic haematopoietic stem cell transplant patients.

Population pharmacokinetics of posaconazole in allogeneic haematopoietic stem cell transplant patients.

Journal: The Journal of antimicrobial chemotherapy

Published: October 11, 2023

A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data.

A Personalized Risk Model for Azacitidine Outcome in Myelodysplastic Syndrome and Other Myeloid Neoplasms Identified by Machine Learning Model Utilizing Real-World Data.

Journal: Cancers

Published: May 27, 2023

Population Pharmacokinetics of Ganciclovir in Allogeneic Hematopoietic Stem Cell Transplant Patients.

Population Pharmacokinetics of Ganciclovir in Allogeneic Hematopoietic Stem Cell Transplant Patients.

Journal: Antimicrobial agents and chemotherapy

Published: February 23, 2023

Application of User-Centered Codesign Principles to Address Barriers in Therapeutic Drug Monitoring.

Application of User-Centered Codesign Principles to Address Barriers in Therapeutic Drug Monitoring.

Journal: Therapeutic drug monitoring

Published: July 29, 2022

Optimizing antifungal prophylaxis in allogeneic stem cell transplantation: A cohort study of two different approaches.

Optimizing antifungal prophylaxis in allogeneic stem cell transplantation: A cohort study of two different approaches.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: July 10, 2022

A Systematic Review of the Clinical Pharmacokinetics, Pharmacodynamics and Toxicodynamics of Ganciclovir/Valganciclovir in Allogeneic Haematopoietic Stem Cell Transplant Patients.

A Systematic Review of the Clinical Pharmacokinetics, Pharmacodynamics and Toxicodynamics of Ganciclovir/Valganciclovir in Allogeneic Haematopoietic Stem Cell Transplant Patients.

Journal: Clinical pharmacokinetics

Published: December 24, 2020

Ceftazidime stability and pyridine toxicity during continuous i.v. infusion.

Ceftazidime stability and pyridine toxicity during continuous i.v. infusion.

Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Published: February 05, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026